Annette I Ferger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Annette I Ferger has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Albert Christian Ludolph
Department of Neurology, Ulm University , Ulm 89081
1 shared publication - Anke Witting
Department of Neurology, Ulm University, DE 89081, Germany
1 shared publication - Irma Merdian
Department of Neurology, Ulm University, Ulm, Germany
1 shared publication - Katharina N Muth
Department of Neurology, Ulm University, Ulm, Germany
1 shared publication - Loretta Campanelli
Department of Neurology, Ulm University, Ulm, Germany
1 shared publication - Valentina Reimer
Department of Neurology, Ulm University, Ulm, Germany
1 shared publication
Latest Publications
- Open Access
- 11 August 2010
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 7 (1) , 45
Effects of mitochondrial dysfunction on the immunological properties of microglia
Background: Neurodegenerative diseases are characterized by both mitochondrial dysfunction and activation of microglia, the macrophages of the brain. Here, we investigate the effects of mitochondrial dysfunction on the activation profile of microglial cells. Methods: We incubated primary mouse microglia with the mitochondrial toxins 3-nitropropionic acid (3-NP) or rotenone. These mitochondrial toxins are known to induce neurodegeneration in humans and in experimental animals. We characterized lipopolysaccharide- (LPS-) induced microglial activation and the alternative, interleukin-4- (IL-4-) induced microglial activation in these mitochondrial toxin-treated microglial cells. Results: We found that, while mitochondrial toxins did not affect LPS-induced activation, as measured by release of tumor necrosis factor α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β), they did inhibit part of the IL-4-induced alternative activation, as measured by arginase activity and expression, induction of insulin-like growth factor 1 (IGF-1) and the counteraction of the LPS induced cytokine release. Conclusions: Mitochondrial dysfunction in microglial cells inhibits part of the IL-4-induced alternative response. Because this alternative activation is considered to be associated with wound healing and an attenuation of inflammation, mitochondrial dysfunction in microglial cells might contribute to the detrimental effects of neuroinflammation seen in neurodegenerative diseases.
- 11 August 2010
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 7 (1) , 45
Open AccessEffects of mitochondrial dysfunction on the immunological properties of microglia
Background: Neurodegenerative diseases are characterized by both mitochondrial dysfunction and activation of microglia, the macrophages of the brain. Here, we investigate the effects of mitochondrial dysfunction on the activation profile of microglial cells. Methods: We incubated primary mouse microglia with the mitochondrial toxins 3-nitropropionic acid (3-NP) or rotenone. These mitochondrial toxins are known to induce neurodegeneration in humans and in experimental animals. We characterized lipopolysaccharide- (LPS-) induced microglial activation and the alternative, interleukin-4- (IL-4-) induced microglial activation in these mitochondrial toxin-treated microglial cells. Results: We found that, while mitochondrial toxins did not affect LPS-induced activation, as measured by release of tumor necrosis factor α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β), they did inhibit part of the IL-4-induced alternative activation, as measured by arginase activity and expression, induction of insulin-like growth factor 1 (IGF-1) and the counteraction of the LPS induced cytokine release. Conclusions: Mitochondrial dysfunction in microglial cells inhibits part of the IL-4-induced alternative response. Because this alternative activation is considered to be associated with wound healing and an attenuation of inflammation, mitochondrial dysfunction in microglial cells might contribute to the detrimental effects of neuroinflammation seen in neurodegenerative diseases.